C07D 223/00
Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only
Official title: Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
C07D223/00 (Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only) appears on 1,904 US grants and 1,584 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,904
- Published applications
- 1,584
- Assignees
- 858
- Inventors
- 5,138
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 32 | 0 |
| 1977 | 30 | 0 |
| 1978 | 30 | 0 |
| 1979 | 29 | 0 |
| 1980 | 29 | 0 |
| 1981 | 25 | 0 |
| 1982 | 24 | 0 |
| 1983 | 21 | 0 |
| 1984 | 22 | 0 |
| 1985 | 26 | 0 |
| 1986 | 26 | 0 |
| 1987 | 21 | 0 |
| 1988 | 25 | 0 |
| 1989 | 30 | 0 |
| 1990 | 20 | 0 |
| 1991 | 31 | 0 |
| 1992 | 23 | 0 |
| 1993 | 36 | 0 |
| 1994 | 27 | 0 |
| 1995 | 30 | 0 |
| 1996 | 40 | 0 |
| 1997 | 57 | 0 |
| 1998 | 47 | 0 |
| 1999 | 42 | 0 |
| 2000 | 36 | 0 |
| 2001 | 33 | 4 |
| 2002 | 40 | 62 |
| 2003 | 52 | 60 |
| 2004 | 36 | 84 |
| 2005 | 32 | 79 |
| 2006 | 57 | 76 |
| 2007 | 43 | 86 |
| 2008 | 45 | 67 |
| 2009 | 35 | 75 |
| 2010 | 43 | 77 |
| 2011 | 44 | 57 |
| 2012 | 51 | 58 |
| 2013 | 61 | 84 |
| 2014 | 59 | 72 |
| 2015 | 68 | 83 |
| 2016 | 61 | 70 |
| 2017 | 77 | 68 |
| 2018 | 35 | 50 |
| 2019 | 63 | 57 |
| 2020 | 39 | 50 |
| 2021 | 31 | 47 |
| 2022 | 37 | 55 |
| 2023 | 27 | 50 |
| 2024 | 19 | 38 |
| 2025 | 33 | 51 |
| 2026 | 24 | 24 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Benzoazepine compound, and composition and use thereof15 Sep 2026US 12,735,398 B2Shanghaitech University
- Process for producing epsilon-caprolactam by depolymerization of polycaprolactam (PA6)18 Aug 2026US 12,709,599 B2Aquafil S.P.A.
- Benzonitric heterocyclic compound, preparation method therefor and use thereof18 Aug 2026US 12,709,600 B2Shanghai Institute of Pharmaceutical Industry
- Tetrahydroisoquinoline compound as potassium channel modulator and preparation and application thereof11 Aug 2026US 12,703,687 B2Shanghai Zhimeng Biopharma, Inc.
- Transcriptional enhanced associate domain (TEAD) transcription factor inhibitors and uses thereof4 Aug 2026US 12,698,259 B2Dana-Farber Cancer Institute, Inc.
- Method for purifying a crystalline substance1 Oct 2026US 2026/0297051 A1China Petroleum & Chemical Corporation
- Dpp1 inhibitors with polycyclic linkers and uses thereof10 Sep 2026US 2026/0265207 A1Insmed Incorporated
- Novel compounds with mtorc2-inhibitory activity and uses thereof10 Sep 2026US 2026/0265267 A1Aliad Biopharma
- Compound as voltage-gated sodium channel inhibitor3 Sep 2026US 2026/0257996 A1Guangzhou Fermion Technology Co., Ltd.
- Heterocyclic compounds as selective hdac6 inhibitors20 Aug 2026US 2026/0242358 A1Miralinc Pharma, Inc.
Most cited
By later US patents
- Pharmaceutical formulations for parenteral use208US 5,024,998 AUniversity of Florida · 1991
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Condensed heterocyclic compounds154US 5,037,825 AHoffmann-La Roche Inc. · 1991
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Azlactone-related dopants in the emissive layer of an OLED141US 6,030,715 AThe Trustees of Princeton University · 2000